CareDx Non Operating Income Net Other from 2010 to 2026
| CDNA Stock | USD 18.80 0.05 0.27% |
Non Operating Income Net Other | First Reported 2014-06-30 | Previous Quarter -2 M | Current Value -268 K | Quarterly Volatility 5.9 M |
Check CareDx financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among CareDx's main balance sheet or income statement drivers, such as Depreciation And Amortization of 21.4 M, Interest Expense of 3.7 M or Selling General Administrative of 55.1 M, as well as many indicators such as Price To Sales Ratio of 3.98, Dividend Yield of 0.0 or PTB Ratio of 3.48. CareDx financial statements analysis is a perfect complement when working with CareDx Valuation or Volatility modules.
CareDx | Non Operating Income Net Other | Build AI portfolio with CareDx Stock |
Analyzing CareDx's Non Operating Income Net Other over time reveals critical patterns in financial health and operational efficiency. This metric helps investors evaluate trends, identify inflection points, and make informed decisions based on historical performance. Understanding how Non Operating Income Net Other has evolved provides context for assessing CareDx's current valuation and future prospects.
Latest CareDx's Non Operating Income Net Other Growth Pattern
Below is the plot of the Non Operating Income Net Other of CareDx Inc over the last few years. It is CareDx's Non Operating Income Net Other historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in CareDx's overall financial position and show how it may be relating to other accounts over time.
| Non Operating Income Net Other | 10 Years Trend |
|
Non Operating Income Net Other |
| Timeline |
CareDx Non Operating Income Net Other Regression Statistics
| Arithmetic Mean | (4,092,213) | |
| Coefficient Of Variation | (217.96) | |
| Mean Deviation | 5,421,597 | |
| Median | (1,920,000) | |
| Standard Deviation | 8,919,339 | |
| Sample Variance | 79.6T | |
| Range | 33.6M | |
| R-Value | (0.08) | |
| Mean Square Error | 84.4T | |
| R-Squared | 0.01 | |
| Significance | 0.77 | |
| Slope | (133,188) | |
| Total Sum of Squares | 1272.9T |
CareDx Non Operating Income Net Other History
About CareDx Financial Statements
CareDx stakeholders use historical fundamental indicators, such as CareDx's Non Operating Income Net Other, to determine how well the company is positioned to perform in the future. Although CareDx investors may analyze each financial statement separately, they are all interrelated. For example, changes in CareDx's assets and liabilities are reflected in the revenues and expenses on CareDx's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in CareDx Inc. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Non Operating Income Net Other | -2.9 M | -3 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether CareDx Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of CareDx's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Caredx Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Caredx Inc Stock:Check out the analysis of CareDx Correlation against competitors. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of CareDx. Projected growth potential of CareDx fundamentally drives upward valuation adjustments. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive CareDx assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Earnings Share 1.28 | Revenue Per Share | Quarterly Revenue Growth 0.252 | Return On Assets | Return On Equity |
Understanding CareDx Inc requires distinguishing between market price and book value, where the latter reflects CareDx's accounting equity. The concept of intrinsic value - what CareDx's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Market sentiment, economic cycles, and investor behavior can push CareDx's price substantially above or below its fundamental value.
It's important to distinguish between CareDx's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding CareDx should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, CareDx's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.